Answers are grounded in this paper and cite their sources.
Five potent TRAIL-sensitizing cytochalasan dimers with unprecedented chemical architectures, named bicytochalasins A-E (1-5), were isolated from the culture of the endophytic fungus Phoma multirostrata XJ-2-1. Compounds 1-5 consist of a typical tricyclic cytochalasan unit and an open-chain cytochalasan moiety, representing the first reported case of cytochalasan dimerization involving an open-chain monomer. These molecules possess two distinct carbon skeletons, each featuring a tetracyclic 5/6/14/6 ring system formed via intermolecular Diels-Alder reactions. Their structures with absolute configurations were elucidated by comprehensive spectroscopic data analysis, electronic circular dichroism (ECD) calculations, and 13C{1H} NMR chemical shift calculation. Compounds 1-5 effectively reverse TRAIL resistance in A549 cells, outperforming the positive control luteolin. Cotreatment with TRAIL (150 ng/mL) and either compound 1 or 5 (10 μM) reduced cell viability by 47.66% and 46.07%, respectively, compared to only 30.22% reduction with luteolin (25 μM). These findings identify bicytochalasins A-E (1-5) as a novel class of TRAIL-sensitizing agents.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: